Invitrocue Appoints Renowned Oncology Researcher Professor Jesús García-Foncillas as Clinical Advisor
January 15, 2019 – Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Jesús García-Foncillas as Clinical Advisor of Invitrocue.
Professor Jesús is an experienced oncology researcher with 25 years of experience in cancer diagnosis and treatment. He holds multiple executive leadership positions at “Fundacion Jimenez Diaz” Autonomous University of Madrid, Spain (FJD-UAM). He is the Director of the University Cancer Institute and the Department of Oncology at FJD-UAM, and the Director of Translational Oncology Division at the Health Research Institute FJD-UAM.
Please click below to read full announcement.